EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer
Abstract
Authors
G Marasco R Silva F Andreguetto Aguiar P Nazareth